Press Release

Blood Glucose Monitoring Systems Market Global Industry Demand, Recent Trends, Size and Share Estimation by 2026 with Top Players – Fortune Business Insight

Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast by 2026 | Global Industry Demand, Recent Trends, Size and Share Estimation

As per the International Diabetes Foundation, the number of adults suffering from diabetes was around 425 million and is expected to reach 630 million by 2045. The prevalence of diabetes is primarily increasing owing to the rapid adoption of sedentary lifestyle and unhealthy food habits.

This further shows that the demand for blood glucose monitoring systems will increase, thereby driving the global blood glucose monitoring systems market.

For more information in the analysis of this report, visit: 

list of key companies mentioned in blood glucose monitoring systems market report,

  • Hoffmann-La Roche Ltd.
  • Abbott
  • Ascensia Diabetes Care Holdings AG
  • Dexcom, Inc.
  • Medtronic
  • Braun Melsungen AG
  • Lifescan Inc.
  • Terumo Medical Corporation
  • DiamonTech GmbH

Fortune Business Insights in a new report, titled “Blood Glucose Monitoring Systems Market Size, Share & Industry Analysis, By Device (Continuous Blood Glucose Monitoring Systems, Self-monitoring of Blood Glucose Systems), By Type (Invasive, Non-invasive), By Modality (Wearable, Non-wearable), By Distribution Channel (Institutional Sales, Retail Sales) and Regional Forecast, 2019-2026” offers an in-depth analysis of the market.

It further provides details on the adoption of blood glucose monitoring devices across several regions. Information on trends, drivers, opportunities, threats, and restraints of the market can help stakeholders to gain valuable insights into the market. The report offers a detailed competitive landscape by presenting information on key players operating in the market.

Request a Sample Copy of the Global Blood Glucose Monitoring Systems Market Research Report:

Major Segmentation includes;

By Device

  • Continuous Blood Glucose Monitoring Systems
  • Self-monitoring of Blood Glucose Monitoring Systems

By Type

  • Non-invasive
  • Invasive

By Modality

  • Wearable
  • Non-wearable

By Distribution Channel

  • Institutional Sales
  • Retail Sales

By Geography

This is a huge cost of burden for diabetic patients. However, the presence of favorable reimbursement healthcare policies plays a fundamental role in the high adoption of blood glucose monitoring systems. Increasing support from private as well as public health insurance agencies is expected to drive the market, especially in developed nations.   this is not the case in developed economies.

For instance, the National Diabetes Services Scheme or NDSS in Australia offers SMBG devices to patients at subsidized rates. Furthermore, around 1.3 million people in Australia registered themselves with NDSS in the year 2018.

More Trending Topics from Fortune Business Insights: 

Sexually Transmitted Diseases Testing Market 2020 Comprehensive Analysis On Revenues, Market Share, Strategies, Growth Rate, Technological Developments

Fetal Bovine Serum Market 2020 – 2026, Details in Relation to the Value, Supply Chain Analysis and Recent Technological Developments

Hematology Analyzers and Reagents Market 2020 Comprehensive Analysis On Revenues, Market Share, Strategies, Growth Rate, Technological Developments

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *